HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Yoshida Selected Research

Biomarkers (Surrogate Marker)

1/2022Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial.
1/2022Protocadherin B9 Is Associated with Tumorigenesis and Cancer Progression in Colorectal Cancer.
1/2022Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.
1/2022Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.
11/2021Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials.
10/2021Postoperative changes in plasma miR21-5p as a novel biomarker for colorectal cancer recurrence: A prospective study.
1/2021MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer.
1/2021Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer.
1/2021Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.
8/2020Tumor Tissue MIR92a and Plasma MIRs21 and 29a as Predictive Biomarkers Associated with Clinicopathological Features and Surgical Resection in a Prospective Study on Colorectal Cancer Patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Yoshida Research Topics

Disease

165Neoplasms (Cancer)
06/2022 - 11/2002
97Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2003
60Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 12/2002
50Neoplasm Metastasis (Metastasis)
05/2022 - 02/2003
36Carcinoma (Carcinomatosis)
03/2022 - 01/2002
26Breast Neoplasms (Breast Cancer)
01/2021 - 11/2002
24Esophageal Neoplasms (Esophageal Cancer)
05/2022 - 05/2006
15Vomiting
03/2022 - 02/2008
15Colonic Neoplasms (Colon Cancer)
05/2021 - 06/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 03/2006
13Nausea
03/2022 - 02/2008
12Adenocarcinoma
09/2022 - 05/2006
12Lymphatic Metastasis
04/2022 - 09/2005
12Neutropenia
06/2019 - 05/2004
10Hemorrhage
05/2022 - 12/2005
10Esophageal Squamous Cell Carcinoma
04/2022 - 08/2004
9Hepatocellular Carcinoma (Hepatoma)
06/2022 - 05/2007
9Carcinogenesis
04/2021 - 11/2002
8Rectal Neoplasms (Rectal Cancer)
02/2022 - 01/2010
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 08/2004
7Infections
01/2022 - 10/2008
6Dehydration (Water Stress)
08/2021 - 10/2006
5Pancreatic Fistula (Pancreatic Fistulas)
07/2022 - 01/2012
5Necrosis
04/2022 - 03/2006
5Abdominal Pain (Pain, Abdominal)
04/2022 - 11/2014
5Stomatitis
01/2022 - 06/2011
4Thrombosis (Thrombus)
03/2022 - 04/2021
4Fever (Fevers)
03/2022 - 01/2010
4Thrombocytopenia (Thrombopenia)
04/2021 - 02/2008
4Triple Negative Breast Neoplasms
01/2021 - 10/2015
4Drug-Related Side Effects and Adverse Reactions
01/2017 - 06/2011
4Exanthema (Rash)
06/2016 - 03/2013
3Pneumonia (Pneumonitis)
04/2022 - 11/2009

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
30Fluorouracil (Carac)FDA LinkGeneric
04/2022 - 12/2002
30Docetaxel (Taxotere)FDA Link
04/2022 - 11/2003
21Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2004
21Messenger RNA (mRNA)IBA
04/2021 - 11/2002
19Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 06/2011
14Cisplatin (Platino)FDA LinkGeneric
04/2022 - 09/2005
12Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 11/2004
12MicroRNAs (MicroRNA)IBA
10/2021 - 02/2010
12DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2003
11Pharmaceutical PreparationsIBA
03/2022 - 01/2003
11Bevacizumab (Avastin)FDA Link
01/2021 - 06/2011
10Biological ProductsIBA
01/2019 - 01/2004
8Monoclonal AntibodiesIBA
01/2021 - 02/2014
8AntiemeticsIBA
01/2018 - 03/2012
8EnzymesIBA
04/2016 - 07/2004
7GemcitabineFDA Link
04/2021 - 11/2010
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 08/2004
7Cetuximab (Erbitux)FDA Link
06/2019 - 02/2016
7Epidermal Growth Factor (EGF)IBA
05/2018 - 01/2005
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 11/2007
7Orotate PhosphoribosyltransferaseIBA
05/2013 - 12/2006
7Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
11/2010 - 12/2002
6Phenobarbital (Luminal)FDA Link
01/2021 - 03/2006
6Leucovorin (Folinic Acid)FDA Link
11/2020 - 12/2013
6Irinotecan (Camptosar)FDA LinkGeneric
06/2019 - 07/2005
6AnthracyclinesIBA
01/2018 - 03/2012
6titanium silicide (TS-1)IBA
08/2005 - 11/2003
5NivolumabIBA
01/2022 - 10/2018
5AntibodiesIBA
04/2021 - 04/2010
5Small Interfering RNA (siRNA)IBA
03/2021 - 02/2013
5Estrogen ReceptorsIBA
01/2021 - 12/2016
5UracilIBA
11/2020 - 07/2014
5TegafurIBA
11/2020 - 07/2014
5Protein Isoforms (Isoforms)IBA
04/2020 - 02/2015
5Capecitabine (Xeloda)FDA Link
02/2019 - 06/2011
5EmeticsIBA
12/2017 - 12/2013
4regorafenibIBA
07/2021 - 12/2016
4Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 07/2012
4AntigensIBA
01/2021 - 08/2007
4CytokinesIBA
01/2021 - 10/2003
4RNA Helicases (RNA Helicase)IBA
04/2019 - 09/2015
4Panitumumab (Vectibix)FDA Link
02/2019 - 02/2014
4ErbB Receptors (EGF Receptor)IBA
05/2018 - 04/2004
4Trastuzumab (Herceptin)FDA Link
07/2017 - 01/2012
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2014 - 03/2003
4Transforming Growth Factor alpha (TGF-alpha)IBA
01/2007 - 10/2003
4PPAR gammaIBA
09/2006 - 01/2003

Therapy/Procedure

95Drug Therapy (Chemotherapy)
05/2022 - 01/2002
79Therapeutics
09/2022 - 01/2002
28Adjuvant Chemotherapy
05/2022 - 01/2002
25Gastrectomy
06/2022 - 04/2002
18Lymph Node Excision (Lymph Node Dissection)
05/2022 - 01/2007
18Hepatectomy
03/2022 - 07/2005
16Neoadjuvant Therapy
01/2022 - 02/2010
15Esophagectomy
05/2022 - 01/2007
9Combination Drug Therapy (Combination Chemotherapy)
10/2019 - 11/2004
8Pancreaticoduodenectomy
07/2022 - 02/2009
6Operative Surgical Procedures
03/2022 - 10/2009
5Pancreatectomy
09/2022 - 04/2011
5Colectomy
07/2021 - 11/2014
5Precision Medicine
07/2018 - 02/2013
4Length of Stay
01/2022 - 11/2013
4Radiotherapy
01/2022 - 07/2007
4Chemoradiotherapy
12/2021 - 09/2005
4Splenectomy
11/2021 - 04/2011
4Conservative Treatment
05/2020 - 12/2005